Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Diabetes Care Inc.

www.abbottdiabetescare.com

Latest From Abbott Diabetes Care Inc.

Abbott Eagerly Awaits Damages Won From DexCom Patent Suit

Abbott’s trial win for patent infringement by DexCom’s CGM systems still doesn’t have information on damages awarded due a hung jury.

Litigation Intellectual Property

JPM Day 1: Abbott Riding In Tandem With Libre 2 Plus & t:slim X2 News

The two diabetes players announced a new integration between their products.

Diabetic Care Deals

Tandem’s CSO Speaks On Insulin Pump Development And Its Challenges

Insulin pumps have lagged behind continuous glucose monitors in terms of market penetration due to their cost and the complex regulatory framework that surrounds them. Elizabeth Gasser, chief strategy officer at Tandem Diabetes spoke to Medtech Insight about these challenges and how the company is taking a slightly different approach to pumps.

Strategy Platform Technologies

Minute Insight: Abbott Teams Up With WeightWatchers In Diabetes Management

The companies will link Abbott’s blood glucose monitoring devices to WeightWatchers’ smartphone apps and weight loss program.

Minute Insights Diabetic Care
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
UsernamePublicRestriction

Register